荣昌生物将处于临床阶段的PD-1/VEGF双特异性抗体RC148授权给艾伯维，交易总金额56亿美元（含首付6.5亿美元）；宜联生物将B7H3 ADC授权罗氏，获得5.7亿美元首付款及近期里程碑付款；海思科PDE3/4双重抑制剂与美国AirNexis Therapeutics公司合作，获得1.08亿美元首付款，总额超10亿美元。这些大额交易的密集落地，构成了2026年开年BD行情的坚实基础。
The ends, she explains, were covered in green enamel.，详情可参考Line官方版本下载
A free tuna melt to anyone who guessed that one correctly.，推荐阅读同城约会获取更多信息
The protests, now in their 13th night, erupted over the economy and have grown into the largest in years.